ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 68

$727K Total Retail Price of All Prescriptions

Rank: 9 out of 68

385 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

22% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 23,293 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

66 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
JANTOVEN 1,053 1,037 1 24
LEVOTHYROXINE SODIUM 804 768 2 2
SIMVASTATIN 792 759 3 1
CITALOPRAM HBR 774 726 4 9
OMEPRAZOLE 773 702 5 5
FUROSEMIDE 718 676 6 3
WARFARIN SODIUM 632 618 7 8
METOPROLOL TARTRATE 590 556 8 6
HYDROCODONE-ACETAMINOPHEN 449 424 S3 9 17
DONEPEZIL HCL 446 446 10 10
GABAPENTIN 405 343 11 12
LISINOPRIL 389 345 12 4
KLOR-CON M20 387 344 13 40
MIRTAZAPINE 317 290 14 15
SENNA PLUS 304 291 15 155
METOPROLOL SUCCINATE 267 246 16 19
POLYETHYLENE GLYCOL 3350 251 210 17 22
MAPAP 250 250 18 124
METFORMIN HCL 247 232 19 14
RISPERIDONE 244 146 20 25
CARVEDILOL 240 209 21 27
HYDROCHLOROTHIAZIDE 239 220 22 11
CLOPIDOGREL 224 207 23 31
VITAMIN D2 218 202 24 147
SERTRALINE HCL 217 217 25 20
QUETIAPINE FUMARATE 216 216 26 33
PRAVASTATIN SODIUM 206 200 27 29
NAMENDA 204 204 28 16
PANTOPRAZOLE SODIUM 202 166 29 30
ASPIRIN EC 192 180 30 182
LANTUS 192 173 30 36
ENALAPRIL MALEATE 189 189 32 61
PREDNISONE 184 167 33 47
AMLODIPINE BESYLATE 184 169 33 7
ISOSORBIDE MONONITRATE ER 181 181 35 35
ATENOLOL 172 172 36 21
ADVAIR DISKUS 170 159 37 41
FLUTICASONE PROPIONATE 166 148 38 66
TAMSULOSIN HCL 166 166 38 28
TRAZODONE HCL 162 145 40 32
ALENDRONATE SODIUM 158 151 41 26
ATORVASTATIN CALCIUM 149 136 42 13
PLAVIX 140 133 43 48
FAMOTIDINE 136 136 44 56
CARBIDOPA-LEVODOPA 135 125 45 50
LORAZEPAM 125 125 46 215
KLOR-CON M10 121 121 47 95
VENLAFAXINE HCL ER 120 94 48 84
IPRATROPIUM-ALBUTEROL 119 112 49 52
DIVALPROEX SODIUM 116 85 50 49
RANITIDINE HCL 116 108 50 34
SEROQUEL 110 107 52 71
SPIRONOLACTONE 108 101 53 88
ESCITALOPRAM OXALATE 108 97 53 38
NYSTATIN-TRIAMCINOLONE 108 105 53 195
PROCRIT 107 107 56 200
OXYCODONE HCL 105 94 S2 57 75
METOLAZONE 104 104 58 189
OXYCONTIN 104 103 S2 58 92
ENOXAPARIN SODIUM 102 25 60 99
OXYBUTYNIN CHLORIDE ER 100 100 61 81
TRIAMCINOLONE ACETONIDE 100 83 61 85
BUMETANIDE 99 99 63 58
CIPROFLOXACIN HCL 99 81 63 55
DIOVAN 96 90 65 42
LEVOFLOXACIN 95 84 66 91
DIGOXIN 94 94 67 45
ALLOPURINOL 89 89 68 46
SPIRIVA 88 77 69 60
OLANZAPINE 87 63 70 82
ZOLPIDEM TARTRATE 85 77 71 53
AMIODARONE HCL 82 82 72 160
VITAMIN B-12 82 82 72 203
LEVETIRACETAM 82 77 72 44
FERROUS SULFATE 80 78 75 242
HUMULIN R 79 75 76 129
CEPHALEXIN 77 76 77 115
NIFEDIPINE ER 75 71 78 79
MUCINEX 75 74 10 78 251
ASPIRIN 75 73 78 171
TRAMADOL HCL 75 75 78 23
OXYBUTYNIN CHLORIDE 73 54 82 89
CYMBALTA 73 63 82 59
DOK 70 70 84 156
MORPHINE SULFATE ER 70 31 S2 84 114
PRAMIPEXOLE DIHYDROCHLORIDE 70 43 84 210
TORSEMIDE 69 69 87 192
CYCLOBENZAPRINE HCL 69 57 R 87 162
FENTANYL 68 61 S2 89 39
NOVOLOG 68 63 89 78
PHENYTOIN SODIUM EXTENDED 67 67 91 118
HYDRALAZINE HCL 67 67 91 51
THERA-M 66 66 93 258
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 55 94 80
LOSARTAN POTASSIUM 65 53 94 37
COMBIVENT 64 60 96 181
LIDODERM 63 56 97 68
POTASSIUM CHLORIDE 63 50 97 18
ROPINIROLE HCL 62 53 99 119
VALPROIC ACID 61 54 100 130
MAG-OXIDE 59 59 10 101 271
HYDROXYZINE HCL 58 58 R 102 151
FLUOXETINE HCL 58 48 102 113
PROPRANOLOL HCL 57 53 104 172
OYST-CAL-D 500 56 49 10 105 277
DOXAZOSIN MESYLATE 56 56 105 123
PHENYTOIN 56 56 105 227
LOVASTATIN 56 56 105 76
TRICOR 55 46 109 125
KALETRA 54 0 110 279
LATANOPROST 54 54 110 63
AGGRENOX 52 48 112 288
LIDOCAINE 52 51 112 288
DILTIAZEM 24HR CD 52 52 112 86
FLUDROCORTISONE ACETATE 51 38 115 294
LAMOTRIGINE 51 37 115 156
ANASTROZOLE 50 50 117 298
PATANOL 50 50 117 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.